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1. Introduction
  Vaginal candidiasis(VC) is a common type of vaginitis, 
a gynecologic disorder that manifests with an odorless 
curdy white discharge (“cottage cheese”) in the female 
lower reproductive tracts with pruritus, irritation, dysuria 
or dyspareunia[1]. It is a common complaint among women 
of different age groups in any society whether or not 
they are sexually active. Some studies have shown high 
preponderance of VC in infective vaginal discharge among 
which studies included 52.5% and 80% isolation rate 
respectively, of Candida species[1,2] . 
  Risk factors for VC are factors that do not seem to be a 
direct cause of the disease, but seem to be associated in 
some way. Having a risk factor for VC makes the chances of 
getting a condition higher but does not always lead to VC. 
Also, the absence of any risk factors or having a protective 
factor does not necessarily guard one against getting 
VC[3]. Some risk factors for VC include pregnancy, poorly 
controlled diabetes, oral contraceptive, antibiotics, immune 
suppression, douches, perfumed feminine hygiene sprays, 
topical antimicrobial agents, tight clothing, tight under-
wears, thyroid disorders and corticosteroid[3].
  VC is caused by the fungus Candida albicans (C. albicans) 
in approximately 85% of cases, while other species such 
as C. glabrata, C. krusei, C. tropicalis and C. stellatoidea 
rarely cause vaginitis[4]. Candida species are usually 
of endogenous origin and may be transmitted by sexual 
partners. Changes in the vaginal environment are usually 
necessary before the organism can induce pathological 
effects.        
   Although VC is both treatable and mild, when left 
untreated, is a possible risk for acquisition of HIV/AIDS as 
well as other complications[5]. Other complications include 
pelvic inflammatory disease, infertility, ectopic pregnancy, 
pelvic abscess, menstrual disorders, spontaneous abortion 
and premature birth. It is now well established that the 
presence of infective vaginal discharge greatly facilitates 
transmission and acquisition of HIV between sexual 
partners[6]. 
  Therefore, there is a need for prevention, early diagnosis 
and prompt treatment of this common condition especially 
among the risk groups, in order to avert the complications 
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and reduce the transmission of HIV. Laboratory support 
is necessary for a differential diagnosis or to confirm the 
clinical diagnosis of VC. 
  The purpose of this study was to investigate VC among 
female patients  attending Aminu Kano Teaching Hospital 
Kano, north-western Nigeria, in order to achieve an 
effective medical management of this condition.
2. Materials and methods                                
  This descriptive study was carried out from December 
2007 to December 2008 in Aminu Kano Teaching Hospital, 
Kano Nigeria. Consent of the patients was received and 
they were assured of strict confidentiality of responses. 
Structured interviewer-administered questionnaire was then 
introduced. Questionnaire included serial number, date, 
age, address, educational status, marital status, occupation, 
last menstrual period, hormonal therapy(yes/no)( if yes, 
type?), antibiotics(yes/no)(if yes, type?), chronic illness(yes/
no) (if yes, type?),  douching ?(yes/no).
  Data were collected from the patients using an interviewer-
administered questionnaire. Endo-cervical and high-
vaginal samples were collected from the patients for 
laboratory analysis. 
2.1. Laboratory  procedure
  Endo-cervical and high vaginal swabs were collected 
following aseptic precautions[4]. The genital swabs 
were immediately sent to the genital bench of medical 
microbiology and parasitology laboratory, Aminu Kano 
teaching hospital where they were processed according to 
standard procedures[4].  Infection with Candida species was 
diagnosed by microscopy of a saline mount, Gram-stained 
smear of material from the vagina and colonial growth on 
Sabouraud’s dextrose agar. 
  A saline mount of the vaginal discharge specimen was 
covered with a cover-slip, and examined microscopically 
at 暳400 magnification, not only to detect yeast cells, but to 
exclude the presence of trichomonads and clue cells. Yeasts 
are round ovoid cells, 4ìm in diameter, showing typical 
budding (blastoconidia). Yeasts can easily be recognized on 
a Gram stained smear as Gram- positive cells. 
  Antibiotic treated selective Sabouraud dextrose agar (SDA) 
was used as a growth medium for the isolation of Candida 
species. After inoculation of the clinical specimen, plates 
were incubated at 36 曟 for 2 days. Colonies of yeast cells 
are opaque white to creamy. 
  A simple test for the identification of C. albicans is the 
germ tube test. A colony was emulsified in 0.5-1 mL of 
sterile serum and incubated at 35-37 曟 for 4 hours. C. 
albicans form germ tubes, short lateral hyphal filaments 
without any constrictions. It was examined every half hour 
for formation of germ tubes. A complete identification of 
Candida species was done by means of sugar assimilation 
test (auxanogram). The yeast was grown on a basal 
carbohydrate-free medium supplemented with essential 
vitamins and the test sugar. Each of the five test sugars, 
namely glucose (positive control), sucrose, trehalose, lactose 
and raffinose was dispensed into each plate. Plates were 
incubated at 30 曟 for 48 hours. Growth  produces an opacity 
in the medium and indicates the ability of the isolates to 
assimilate a sugar.      
  Trichomonas vaginalis was diagnosed by microscopy 
of a saline mount for the actively motile, spear shaped 
flagellates. Gardnerella vaginalis, an agent of bacterial 
vaginosis, was diagnosed by Whiff test and the evaluation of 
Gram stained vaginal smear at oil immersion power( 伊1 000) 
objective  for Clue cells, usually representing at least 20 
percent of vaginal epithelial cells.
   Cervical specimens were Gram-stained and cultures were 
inoculated on plates of Chocolates and Thayer-Martins 
(Oxoid) media and incubated at 37 曟 in a moisturized 
candle extinction jar for 24 to 72 hours. Neisseria 
gonorrhoeae was identified by typical colonial morphology, 
reactions to Gram-stain, positive oxidase test, and sugar 
fermentation. The antibiotic sensitivity of isolates was tested 
by the agar diffusion method on chocolate agar plates using 
oxoid multi-discs with standard antibiotic concentrations. 
The samples collection, transportation and processing 
including microscopy, culture and biochemical tests were 
carried out according to recommended standard[4]. 
  The results were analyzed using SPSS 11.0 statistical 
software; chi-square(x2) was used to compare association 
between proportions and P-values<0.05 were considered 
significant at 95.0% confidence level. 
  Approval of the study protocol was obtained from the 
Ethics Committee of Aminu Kano Teaching Hospital. 
3. Results   
  Eight hundred and forty Candida species were detected, 
constituting 60% of 1 400 female genital discharge samples 
of microbial etiology in a total of 2 000 female genital 
samples received. Candida species were arranged according 
to the age groups of the patients ranging from 0-60 years. In 
the age ranged 0-10 years, 10 (1.1%) out of the 840 Candida 
species were detected, in age group of 11-20 years  206 
(24.5%) Candida species were recorded, 360 (42.9%) aged 
21-30 years, 200 (23.8%) aged 31-40 years, 60 (7.1%) aged 
41-50 years and only 4 (0.5%) aged 51-60 years. The peak 
age bracket at risk was 21-30 years which constituted 360 
(42.9%).  There were multiple isolates in 40 genital samples 
(Table 1).
  Pregnant women that presented with VC constituted 40% 
(n=336) of the total 840 cases. Other risk groups included the 
immunosuppression with 24% (n=202), group with  hormonal 
therapy 15% (n=126), broad spectrum antibiotics  users 16% 
(n=134) and undetermined factors 5% (n=42) (Table 2). In a 
population of 202 immunosuppressed patients with abnormal 
vaginal discharge, 102 (50%) with HIV/AIDS, 60 (30%) with 




  VC was a leading cause of abnormal vaginal discharge 
in the study constituting 60% (n=820) of the 1 400 female 
genital discharge of microbial causes out of the 2 000 female 
genital samples. The result was similar to some earlier 
studies which recorded 52.5% and 80% respectively[1,2]. 
Predominance of candidiasis in the study was in the 
group aged 21-30. The age decade of 21-30 is the most 
sexually active age group with highest risk of pregnancies, 
indulgence in family planning pills and immunosuppression 
due to HIV/AIDS. The inflammation of the vagina, as in any 
inflammatory STI, increases the risk of acquisition of HIV[3,7]. 
Candidiasis is not usually sexually transmitted, though male 
contacts should be seen, firstly, if they have symptoms, and 
secondly, if the woman is having  recurrence.
  C. albicans isolated was 708(84%) out of the total 840 
Candida species while Non-albicans contributed 16% 
(n=132).  The result was in keeping with other studies, which 
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reported that vulvo-vaginal candidiasis(VVC) is created by 
the fungus C. albicans in approximately 85% of cases, with 
C. glabrata being responsible for the remaining 15%[4]. An 
explanation for the predominance of C. albicans in the study 
may be that these species are more predominant than other 
Candida species in the environment and hence more in 
human body. More importantly, it is their favorable survival 
ability in a depressed human immune system.
  Pregnant mothers with VVC in the study constituted 
40% of the total cases seen. Some studies have implicated 
pregnancy as an important risk factor for vaginitis[2,4]. The 
relationship between pregnancy and VC indicates increase 
in hormonal influences and alteration in vaginal PH.
  Immunosuppressed patients recorded 24% risk in the 
study. Systemic condition such as diabetic mellitus, HIV/
AIDS, organ transplants and any chronic debilitating illness 
can increase the woman’s chances of developing VVC[3,5]. 
Depressed cell mediated immunity provides a favorable 
condition for growth of Candida species such as in HIV/
AIDS, where as dysfunction of neutrophils and monocytes 
favors candidal growth in diabetes mellitus[6,7].
  Broad spectrum antibiotic users posed a 16% risk to VC 
in the study. Antibiotics and vaginal douching suppress 
normal bacterial flora and allow Candida organisms 
to proliferate. Of interest is that sulfonamide decrease 
neutrophil intracellular killing of Candida organisms and 
tetracyclines and amino glycosides have been shown to 
decrease neutrophil phagocytosis[7,8].  
  Patients on hormonal therapy contributed 15% risk to VVC. 
The study included patients on oral or injection or implants 
or intrauterine contraceptive device (IUCD). Hormonal 
therapy leads to an inter-play between hormonal influences 
and alteration in vaginal PH[8]. The normal mature vagina 
has a PH of 4.0.
  Limitation in the study includes inability to identify most of 
the non-albicans species owing to lack of some test sugars.
  We recommend prevention, early diagnosis and prompt 
treatment of VC and VVC especially among the risk 
groups in order to avert the complications and reduce HIV 
transmission.
  In conclusion, the result shows that Candida species has 
assumed the role of the most common cause of vaginitis, 
with C. albicans as the most prevalent species. Vulvo-VC 
was common in young adults of age range of 21-30 years, 
pregnant mothers, immunosuppressed, contraceptive and 
broad spectrum antibiotic users. Proper management of VC 
and VVC is recommended especially among the risk groups 
in order to avert complications and reduce HIV transmission. 
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Table 1  
Distribution of Candida organisms in the infective female genital  discharge.          





Candida albicans Non-albicans Other Microbial agents
  0-10     20     12     8     2     2
11-20   440   346 186   20 140
21-30   780   558 300   60 198
31-40   540   420 160   40 220
41-50   180     60   50   10 -
51-60     40       4     4 - -
Total 2 000 1 400 708 132 560
** 20 samples had multiple isolates.
Table 2  
Distribution of VC in relation to pregnancy,  hormonal therapy and broad spectrum antibiotics. 
Age in years VC Pregnant women Hormonal therapy    Antibiotics Immune-Suppress ed
  0-10   10 - - - 10
11-20 206   76 30 24 52
21-30 360 200 60 10 80
31-40 200   60 36 40
41-50   60 - - 34 56
51-60     4 - - -   4
Total 840(100%) 336(40.0%) 126(15.0%) 134(16.0%) 202(24.0%)
